Patents - Global Data - Dimensions
Application
Probiotics for preventing or treating coronavirus-related diseases and/or symptoms
Applicants
- DuPont (Denmark)
[NORA names: DuPont; Private Research; Denmark; Europe, EU; Nordic; OECD]
Abstract
The present invention relates to bacterial strains, compositions comprising bacterial strains, and methods and uses of said strains and compositions for: 1) Preventing or treating a coronavirus-related disease and/or symptom in a subject in need thereof, and/or 2) prolonging immunization of the subject in need thereof against a coronavirus-induced disease after the subject has previously developed: a) Exposure to the coronavirus; b) Recovering from a disease caused by infection with said coronavirus; and/or c) vaccinating against said coronavirus.
Patent Family Records (8)
Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2024, US-11883446-B2
PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES
DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2023, EP-4178597-A2
Probiotics for preventing or treating coronavirus-related diseases and/or symptoms
DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY STEPHANE, LEHTINEN MARKUS, RATHWALA SUJATHA ASHOK, (...more)
2023, CN-116018152-A
PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES
DANISCO US INC, DUPONT NUTRITION BIOSCI APS, DuPont (Denmark), DuPont (United States) GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2022, WO-2022011271-A3
PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES
DANISCO US INC, DUPONT NUTRITION BIOSCI APS, DuPont (Denmark), DuPont (United States) GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2022, WO-2022011271-A2
PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES
DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2022, US-20220370519-A1
PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES
DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2022, US-20220008488-A1
Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses
DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)
2022, US-11318174-B2